Top Markets
#1 Status Status +26.96%
#2 Ontology Gas Ontology Gas +26.36%
#3 EXOD EXOD +22.08%
#4 ETHGas ETHGas +11.00%
#5 Fake World Assets Fake World Assets +10.37%
#6 aelf aelf +9.25%
#7 The Black Bull The Black Bull +8.43%
#8 Derive Derive +8.38%
#9 Gas Gas +8.36%
#10 Ontology Ontology +6.93%
Coin of the day
Status Status
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
RVL Pharmaceuticals plc RVL Pharmaceuticals plc

RVL Pharmaceuticals plc

OSMT
Classifica tra le azioni #25636
Osmotica Pharmaceuticals plc, headquartered in Bridgewater, New Jersey,... Osmotica Pharmaceuticals plc, headquartered in Bridgewater, New Jersey, operates as a fully integrated biopharmaceutical company. The firm's primary focus involves the development and commercialization of various pharmaceutical products, serving markets in the United States, Argentina, and Hungary. Their actively promoted product lineup includes M-72, an extended-release methylphenidate hydrochloride tablet designed to treat attention deficit hyperactivity disorder (ADHD), and Osmolex ER, an extended-release amantadine formulation used for Parkinson's disease and specific drug-induced movement disorders in adults. They also offer Upneeq, an oxymetazoline hydrochloride ophthalmic solution prescribed for blepharoptosis (drooping eyelids). In their development pipeline, Arbaclofen extended-release tablets are currently undergoing Phase III clinical trials for managing spasticity associated with multiple sclerosis, while OS870 is in Phase I trials for neurodegenerative disorders. Beyond these, Osmotica provides women's health solutions, such as Divigel for menopause management and OB Complete, a dietary supplement tailored for the prenatal, pregnancy, and postnatal periods. The company's broader portfolio also encompasses numerous non-promoted pharmaceutical products. These include methylphenidate ER tablets for ADHD, venlafaxine ER tablets addressing major depressive and social anxiety disorders, hydromorphone ER for pain relief, and nifedipine ER for hypertension. Other offerings feature sodium benzoate/sodium phenylacetate for hyperammonemia, oxybutynin ER for overactive bladder, and prescription prenatal vitamins. Additionally, their non-promoted items comprise Lorzone, an immediate-release chlorzoxazone for acute musculoskeletal pain (when combined with rest and physical therapy), ConZip (tramadol hydrochloride) for pain management, and nitrofurantoin for urinary tract infections, alongside Osmodex and various other abbreviated new drug applications.
Prezzo delle azioni
$1.11
Ultima sincronizzazione: 2022-01-18
Capitalizzazione di mercato
$47.57M
Variazione (1 giorno)
-1.77%
Variazione (1 anno)
0.00%
Paese
US
Scambia RVL Pharmaceuticals plc (OSMT)

Categoria

Healthcare
Storico dividendi per RVL Pharmaceuticals plc (OSMT)
RVL Pharmaceuticals plc (simbolo azionario: OSMT) ha effettuato un totale di 0 pagamenti di dividendi.
La somma totale dei dividendi (rettificata per split azionari) è: 0.00
Rendimento da dividendo (TTM): 0
Pagamenti dei dividendi per RVL Pharmaceuticals plc (OSMT) dal 2026 al 2026
Pagamenti annuali dei dividendi
Anno Dividendo (rettificato per split azionari) Cambia
Non abbastanza dati per le date fornite.
Elenco di tutti i pagamenti di dividendi
Anno Dividendo Cambia
Non abbastanza dati per le date fornite.
Dividendi di aziende simili o concorrenti
Azienda Numero di pagamenti di dividendi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US